Mega Mergers in Big Pharma: What's driving them?

Posted by Laura Swartz

November 9, 2015 at 5:38 PM

In just six months, drug companies have spent $221 billion buying each other, with a lot of recent mergers being between biotech firms. So what is driving the deals? Business television show Arise Xchange sits down with Jeff Kraws, Cofounder and CEO of Crystal Research Associates, to discuss. 

Runtime: 3:38 minutes

 

Read More

Topics: Crystal Research Associates, biopharmaceuticals

Updated business outlook available on Peregrine Pharmaceuticals

Posted by Laura Swartz

January 24, 2011 at 10:01 AM

We at Crystal are looking forward to an exciting week as we begin releasing new research in our revamped Coverage Library. This morning, we published a business update on innovative biopharmaceutical company, Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ).

Read More

Topics: New Research, biopharmaceuticals

Bioniche Named Among Top Employers in Canada

Posted by Laura Swartz

October 28, 2010 at 10:40 AM

Today, Bioniche Life Sciences Inc. (BNC-TSX), a research-based, technology-driven Canadian biopharmaceutical company, announced that it was named among the Top 50 Best Small and Medium Employers in Canada. Ranked 14th, Bioniche believes that its employees, who are also shareholders, are among the Company’s greatest assets. The rankings were determined using employee opinion surveys, an assessment of organization practices, and perspectives from the leadership team. More than 160 companies across Canada registered to participate in the study, which was conducted by the Queen’s Centre for Business Venturing, the Queen’s University School of Business, and Aon Hewitt.

Read More

Topics: Newsworthy Events, Bioniche, biopharmaceuticals

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic